Glioblastoma Multiforme (GBM) is one of the most aggressive and challenging brain cancers, with limited treatment options and a poor prognosis. The complexity of this disease, coupled with its resistance to conventional therapies, has created a significant unmet need in the Glioblastoma Multiforme (GBM) treatment market. As research advances, new therapeutic approaches and...